$ 131.75
Key Takeaways
Risk factor
Negligible price volatility
Profitability factor
Very strong margins and returns
About
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive...
Company Valuation
Based on key historical and expected multiples, the stock is overvalued relative to its peers. Specifically, the stock is fairly valued on P/E, overvalued on EV/EBITDA, o
Target Price
The average target price of ABT is 142 and suggests 8% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation sug
